Introduction and History of the Chemistry of Nucleic Acids Therapeutics View Full Text


Ontology type: schema:Chapter      Open Access: True


Chapter Info

DATE

2022-02-25

AUTHORS

Michael J. Gait , Sudhir Agrawal

ABSTRACT

This introduction charts the history of the development of the major chemical modifications that have influenced the development of nucleic acids therapeutics focusing in particular on antisense oligonucleotide analogues carrying modifications in the backbone and sugar. Brief mention is made of siRNA development and other applications that have by and large utilized the same modifications. We also point out the pitfalls of the use of nucleic acids as drugs, such as their unwanted interactions with pattern recognition receptors, which can be mitigated by chemical modification or used as immunotherapeutic agents. More... »

PAGES

3-31

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/978-1-0716-2010-6_1

DOI

http://dx.doi.org/10.1007/978-1-0716-2010-6_1

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1145845039

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/35213007


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/03", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Chemical Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/0303", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Macromolecular and Materials Chemistry", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Nucleic Acids", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Oligonucleotides", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Oligonucleotides, Antisense", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "RNA, Small Interfering", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Medical Research Council Laboratory of Molecular Biology, Cambridge, UK", 
          "id": "http://www.grid.ac/institutes/grid.42475.30", 
          "name": [
            "Medical Research Council Laboratory of Molecular Biology, Cambridge, UK"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Gait", 
        "givenName": "Michael J.", 
        "id": "sg:person.01105545530.71", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01105545530.71"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Arnay Sciences LLC, Shrewsbury, MA, USA", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "University of Massachusetts Medical School, Worcester, MA, USA", 
            "Arnay Sciences LLC, Shrewsbury, MA, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Agrawal", 
        "givenName": "Sudhir", 
        "id": "sg:person.01124454740.04", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01124454740.04"
        ], 
        "type": "Person"
      }
    ], 
    "datePublished": "2022-02-25", 
    "datePublishedReg": "2022-02-25", 
    "description": "This introduction charts the history of the development of the major chemical modifications that have influenced the development of nucleic acids therapeutics focusing in particular on antisense oligonucleotide analogues carrying modifications in the backbone and sugar. Brief mention is made of siRNA development and other applications that have by and large utilized the same modifications. We also point out the pitfalls of the use of nucleic acids as drugs, such as their unwanted interactions with pattern recognition receptors, which can be mitigated by chemical modification or used as immunotherapeutic agents.", 
    "editor": [
      {
        "familyName": "Arechavala-Gomeza", 
        "givenName": "Virginia", 
        "type": "Person"
      }, 
      {
        "familyName": "Garanto", 
        "givenName": "Alejandro", 
        "type": "Person"
      }
    ], 
    "genre": "chapter", 
    "id": "sg:pub.10.1007/978-1-0716-2010-6_1", 
    "isAccessibleForFree": true, 
    "isPartOf": {
      "isbn": [
        "978-1-0716-2009-0", 
        "978-1-0716-2010-6"
      ], 
      "name": "Antisense RNA Design, Delivery, and Analysis", 
      "type": "Book"
    }, 
    "keywords": [
      "nucleic acid therapeutics", 
      "chemical modification", 
      "major chemical modifications", 
      "antisense oligonucleotide analogs", 
      "oligonucleotide analogues", 
      "nucleic acids", 
      "unwanted interactions", 
      "chemistry", 
      "modification", 
      "backbone", 
      "same modifications", 
      "therapeutics", 
      "acid", 
      "analogues", 
      "interaction", 
      "introduction", 
      "brief mention", 
      "agents", 
      "sugars", 
      "applications", 
      "drugs", 
      "development", 
      "use", 
      "receptors", 
      "immunotherapeutic agents", 
      "pitfalls", 
      "mention", 
      "recognition receptors", 
      "history", 
      "pattern recognition receptors"
    ], 
    "name": "Introduction and History of the Chemistry of Nucleic Acids Therapeutics", 
    "pagination": "3-31", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1145845039"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/978-1-0716-2010-6_1"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "35213007"
        ]
      }
    ], 
    "publisher": {
      "name": "Springer Nature", 
      "type": "Organisation"
    }, 
    "sameAs": [
      "https://doi.org/10.1007/978-1-0716-2010-6_1", 
      "https://app.dimensions.ai/details/publication/pub.1145845039"
    ], 
    "sdDataset": "chapters", 
    "sdDatePublished": "2022-12-01T06:49", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20221201/entities/gbq_results/chapter/chapter_233.jsonl", 
    "type": "Chapter", 
    "url": "https://doi.org/10.1007/978-1-0716-2010-6_1"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/978-1-0716-2010-6_1'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/978-1-0716-2010-6_1'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/978-1-0716-2010-6_1'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/978-1-0716-2010-6_1'


 

This table displays all metadata directly associated to this object as RDF triples.

125 TRIPLES      22 PREDICATES      59 URIs      52 LITERALS      12 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/978-1-0716-2010-6_1 schema:about N73dabb2158f247cda83f61faad121499
2 N9b1f0ec42267467693540f7e0689667e
3 Ndbf44775f8644d78996dc924e68f6052
4 Nf43ceb5737d94aad9673b747779ee459
5 anzsrc-for:03
6 anzsrc-for:0303
7 schema:author N44139c7a4b8246f4a3840d73d13c3b30
8 schema:datePublished 2022-02-25
9 schema:datePublishedReg 2022-02-25
10 schema:description This introduction charts the history of the development of the major chemical modifications that have influenced the development of nucleic acids therapeutics focusing in particular on antisense oligonucleotide analogues carrying modifications in the backbone and sugar. Brief mention is made of siRNA development and other applications that have by and large utilized the same modifications. We also point out the pitfalls of the use of nucleic acids as drugs, such as their unwanted interactions with pattern recognition receptors, which can be mitigated by chemical modification or used as immunotherapeutic agents.
11 schema:editor N42e7532279de4ee9933136853dc6b60c
12 schema:genre chapter
13 schema:isAccessibleForFree true
14 schema:isPartOf N2a5961e0f3ef43169c6891c35275481e
15 schema:keywords acid
16 agents
17 analogues
18 antisense oligonucleotide analogs
19 applications
20 backbone
21 brief mention
22 chemical modification
23 chemistry
24 development
25 drugs
26 history
27 immunotherapeutic agents
28 interaction
29 introduction
30 major chemical modifications
31 mention
32 modification
33 nucleic acid therapeutics
34 nucleic acids
35 oligonucleotide analogues
36 pattern recognition receptors
37 pitfalls
38 receptors
39 recognition receptors
40 same modifications
41 sugars
42 therapeutics
43 unwanted interactions
44 use
45 schema:name Introduction and History of the Chemistry of Nucleic Acids Therapeutics
46 schema:pagination 3-31
47 schema:productId N6056d3b9f97245c6a8ea20dd7829a3b1
48 N9931a83848704e389a47f6cb241329bf
49 Nfed9a858ebde4f448311c23042608239
50 schema:publisher N817b8f42ce5342f1bac9bf94d4cc238b
51 schema:sameAs https://app.dimensions.ai/details/publication/pub.1145845039
52 https://doi.org/10.1007/978-1-0716-2010-6_1
53 schema:sdDatePublished 2022-12-01T06:49
54 schema:sdLicense https://scigraph.springernature.com/explorer/license/
55 schema:sdPublisher N03e4de90f1cb4832ab5b2c6a8576b3b8
56 schema:url https://doi.org/10.1007/978-1-0716-2010-6_1
57 sgo:license sg:explorer/license/
58 sgo:sdDataset chapters
59 rdf:type schema:Chapter
60 N03e4de90f1cb4832ab5b2c6a8576b3b8 schema:name Springer Nature - SN SciGraph project
61 rdf:type schema:Organization
62 N0d8a07fd19c44d4b9071b80028f532a3 schema:familyName Garanto
63 schema:givenName Alejandro
64 rdf:type schema:Person
65 N2a5961e0f3ef43169c6891c35275481e schema:isbn 978-1-0716-2009-0
66 978-1-0716-2010-6
67 schema:name Antisense RNA Design, Delivery, and Analysis
68 rdf:type schema:Book
69 N42e7532279de4ee9933136853dc6b60c rdf:first N68f454865f3741a989d473ad942ac79d
70 rdf:rest Nde13bbc731de49cb969508d1c1517ddb
71 N44139c7a4b8246f4a3840d73d13c3b30 rdf:first sg:person.01105545530.71
72 rdf:rest N5dffe23287514cc8beae0dd0a76a4763
73 N5dffe23287514cc8beae0dd0a76a4763 rdf:first sg:person.01124454740.04
74 rdf:rest rdf:nil
75 N6056d3b9f97245c6a8ea20dd7829a3b1 schema:name pubmed_id
76 schema:value 35213007
77 rdf:type schema:PropertyValue
78 N68f454865f3741a989d473ad942ac79d schema:familyName Arechavala-Gomeza
79 schema:givenName Virginia
80 rdf:type schema:Person
81 N73dabb2158f247cda83f61faad121499 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
82 schema:name Oligonucleotides, Antisense
83 rdf:type schema:DefinedTerm
84 N817b8f42ce5342f1bac9bf94d4cc238b schema:name Springer Nature
85 rdf:type schema:Organisation
86 N9931a83848704e389a47f6cb241329bf schema:name doi
87 schema:value 10.1007/978-1-0716-2010-6_1
88 rdf:type schema:PropertyValue
89 N9b1f0ec42267467693540f7e0689667e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
90 schema:name Oligonucleotides
91 rdf:type schema:DefinedTerm
92 Ndbf44775f8644d78996dc924e68f6052 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
93 schema:name Nucleic Acids
94 rdf:type schema:DefinedTerm
95 Nde13bbc731de49cb969508d1c1517ddb rdf:first N0d8a07fd19c44d4b9071b80028f532a3
96 rdf:rest rdf:nil
97 Nf43ceb5737d94aad9673b747779ee459 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
98 schema:name RNA, Small Interfering
99 rdf:type schema:DefinedTerm
100 Nfed9a858ebde4f448311c23042608239 schema:name dimensions_id
101 schema:value pub.1145845039
102 rdf:type schema:PropertyValue
103 anzsrc-for:03 schema:inDefinedTermSet anzsrc-for:
104 schema:name Chemical Sciences
105 rdf:type schema:DefinedTerm
106 anzsrc-for:0303 schema:inDefinedTermSet anzsrc-for:
107 schema:name Macromolecular and Materials Chemistry
108 rdf:type schema:DefinedTerm
109 sg:person.01105545530.71 schema:affiliation grid-institutes:grid.42475.30
110 schema:familyName Gait
111 schema:givenName Michael J.
112 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01105545530.71
113 rdf:type schema:Person
114 sg:person.01124454740.04 schema:affiliation grid-institutes:None
115 schema:familyName Agrawal
116 schema:givenName Sudhir
117 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01124454740.04
118 rdf:type schema:Person
119 grid-institutes:None schema:alternateName Arnay Sciences LLC, Shrewsbury, MA, USA
120 schema:name Arnay Sciences LLC, Shrewsbury, MA, USA
121 University of Massachusetts Medical School, Worcester, MA, USA
122 rdf:type schema:Organization
123 grid-institutes:grid.42475.30 schema:alternateName Medical Research Council Laboratory of Molecular Biology, Cambridge, UK
124 schema:name Medical Research Council Laboratory of Molecular Biology, Cambridge, UK
125 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...